Dr. Péter Ferdinandy, MD, PhD, MBA
Vice-Rector

Citizenship:
Hungarian

Date and place of birth:
1966, Békéscsaba

Email: sci.vicerector@semmelweis-univ.hu

Current positions

2018 – ongoing Vice-Rector for Science and Innovations, Semmelweis University
2011 -ongoing

Professor & Director, Department of Pharmacology and Pharmacotherapy, Medical Faculty – Semmelweis University, Budapest, Hungary.

2005 – 2019 Professor of Biochemistry (part-time), Head of the Cardiovascular Research Group – University of Szeged, Hungary
2003 – ongoing Founder and CEO of Pharmahungary Group,  Szeged, Hungary (spin-off companies)


Education and Scientific degrees

2004 DSc in medical sciences, Hungarian Academy of Sciences
2000-2004 MBA (Masters of Business Administration, Finance and Quality management), Budapest Technical University, Hungary
1999 Designation as registered Clinical-Pharmacologist
1997-1999 Postdoctoral training, Dept Pharmacology, University of Alberta, Edmonton, Canada
1995 December

PhD in biochemistry (score: excellent, “summa cum laude”)

1991-1995 PhD training, Departments of Physiology and Biochemistry, University of Szeged, Hungary
1991 September MD diploma (score: excellent, “summa cum laude”)
1985-1991 University of Szeged, Hungary


Teaching experience:

2004- Lecturer in Pharmacology, Semmelweis University, Budapest
1993- Lecturer in Biochemistry, University of Szeged, Hungary
1998-1999 Lecturer in Pharmacology, University of Alberta, Edmonton, Canada
1991-1994 Lecturer in Physiology, University of Szeged, Hungary


Scholarships, fellowships

1989-1991                 Scholarship of Hungarian Republic

1997-1999:                 Postdoc Fellow, MRC Canada, University of Alberta, Canada

2001-2005                  Szechenyi professorship, Hungarian Academy of Sciences

2013-2014                  Szentagothai professorship, National Excellence Program


Major awards

First prize, Young Investigator Award 1999, International Society for Heart Research

Major leadership positions at international scientific organizations

President
(2012-2014)
International Society for Heart Research, European Section
Chairman
(2014-2016)
Working Group Cell Biology of the Heart, European Cardiology Society
President(2019-2023) Hungarian Society of Experimental and Clinical Pharmacology


Editorial board memberships

  • Editor-in-Chief: British Journal of Pharmacology, from Jan 1, 2023
  • Br J Pharmacol (Reviews Editor, Guest Editor, impakt factor 4.9)
  • J Mol Cell Cardiol (Editor, impakt factor 5.1)
  • Basic Res Cardiol (Editor, impakt factor 5.9)
  • J Pharmacol Tox Methods (Editor, impakt factor 2.2)
  • Vascular Pharmacology (Editor, impakt factor 3.7)

Languages

  • Native language: Hungarian
  • English (fluent)
  • German (basic understanding)

Scientometric data

  • Number of papers in international peer-reviewed journals: over 340 (source: PubMed)
  • Cumulative impact factor of full papers: over 1600
  • Total number of citations: over 23000, Hirsch index: 75 (source: Google Scholar)
  • Patent families: 6, software developments: 3 on the market
  • Listed on HIGHLYCITED researchers in 2014; 2017, 2020, 2021, 2022, 2023 (list of the most influential “highly cited” scientists)